Parkinson's Disease Trial, Recruiting (NCT06161636)

Parkinson's Disease Trial, Recruiting NCT06161636 Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06161636 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Parkinson's disease or a related condition that causes similar movement symptoms
Your movement-related symptoms from Parkinson's or a related condition have been present for 6 years or less
You are a healthy volunteer with no history of neurological conditions (the trial appears to include both patients and healthy volunteers)
You are between 50 and 75 years old
If you take Parkinson's medication, you are able to safely go without it for 12 hours before a morning visit, if required

Who may not be able to join:

You have a major condition affecting memory, thinking, or mental function
You have a history of other neurological conditions, such as stroke, limb paralysis, traumatic brain injury, epilepsy, involuntary facial muscle movements, or uncontrollable tremor not related to Parkinson's
You have had a surgical or medical procedure involving your jaw, mouth, or voice box
You have hearing loss that has not been corrected with a hearing aid or other treatment
You have a medical reason why eye drops used to widen the pupil of your eye cannot be safely used (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pierre Blanchet, CHUM/Université de Montréal

Phone: 514-890-8123

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06161636

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 514-890-8123

More information: https://clinicaltrials.gov/study/NCT06161636

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Parkinson's disease or a related condition that causes similar movement symptoms
Your movement-related symptoms from Parkinson's or a related condition have been present for 6 years or less
You are a healthy volunteer with no history of neurological conditions (the trial appears to include both patients and healthy volunteers)
You are between 50 and 75 years old
If you take Parkinson's medication, you are able to safely go without it for 12 hours before a morning visit, if required

Who may not be able to join:

You have a major condition affecting memory, thinking, or mental function
You have a history of other neurological conditions, such as stroke, limb paralysis, traumatic brain injury, epilepsy, involuntary facial muscle movements, or uncontrollable tremor not related to Parkinson's
You have had a surgical or medical procedure involving your jaw, mouth, or voice box
You have hearing loss that has not been corrected with a hearing aid or other treatment
You have a medical reason why eye drops used to widen the pupil of your eye cannot be safely used (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Registry

ClinicalTrials.gov

Start date

19 February 2020

Est. completion

1 December 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Lognormal primitives

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov